Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid-19 vaccine in a middle-aged woman.
Kosuke KobayashiYasuhiro HamataniKoki MoriyoshiMoritake IguchiNobutoyo MasunagaMariko TerashimaMitsuru AbeNozomu SasahashiMasaharu AkaoPublished in: ESC heart failure (2022)
We describe a 51-year-old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second-dose Covid-19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 50% were noted. We also found the multiple organ damage, including mucocutaneous, gastrointestinal, and neurologic systems. In addition, we revealed the positive results for anti-nucleocapsid SARS-CoV-2 IgG, albeit negative for SARS-CoV-2 polymerase chain reaction testing, suggesting the prior asymptomatic Covid-19 infection. We finally diagnosed her as multisystem inflammatory syndrome after vaccination. Of note, we obtained myocardial specimen from the patients and demonstrated the lymphohistiocytic myocarditis, which is a rare form of myocarditis.
Keyphrases
- sars cov
- ejection fraction
- aortic stenosis
- respiratory syndrome coronavirus
- left ventricular
- case report
- coronavirus disease
- oxidative stress
- middle aged
- end stage renal disease
- heart failure
- chronic kidney disease
- newly diagnosed
- prognostic factors
- mitral valve
- transcatheter aortic valve replacement
- peritoneal dialysis
- single cell
- aortic valve
- left atrial
- acute coronary syndrome
- binding protein